Macquarie Focused International Core ETF

The Macquarie Focused International Core ETF (EXUS) is a passively managed exchange-traded fund that tracks the MSCI World ex USA Index, providing diversified exposure to large- and mid-cap stocks outside the United States. The fund’s portfolio is heavily weighted toward the finance sector (approximately 26%) and health technology (about 10%), with the majority of assets located in Europe (59%), followed by Asia (22%) and North America (11%). Top holdings include SAP SE and ASML Holding NV. EXUS has seen strong asset growth, with assets under management reaching $2.93 billion and a one-year price performance increase of 15.64%. The ETF does not pay dividends and has a low expense ratio of 0.15%. Shares are issued by Deutsche Bank AG under the Xtrackers brand, and the fund was launched on March 6, 2024.

Macquarie Focused International Core ETF trades as EXUS on NASDAQ. The company is classified in Financial Services / Asset Management - Global and reports in USD.

The current profile places the business in Asset Management - Global. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Macquarie Focused International Core ETF can be compared against peers such as Bitwise Web3 ETF, MAX Auto Industry 3X Leveraged ETN, iShares Environmental Infrastructure and Industrials ETF, Invesco MSCI Green Building ETF, KraneShares 2X Long BABA Daily ETF​, Pacer BlueStar Digital Entertainment ETF.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $5.41M, beta of 1.17, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

EXUS currently shows total debt of N/A and beta of 1.17. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://etf.macquarie.com/us/en.html

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.